Clinical trial
Continuous Subcutaneous Infusion of Pramlintide and Insulin
NCT00291772 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00291772 |
|---|---|
| Title | Continuous Subcutaneous Infusion of Pramlintide and Insulin |
| Official title | Continuous Subcutaneous Infusion of Pramlintide and Insulin: A Randomized, Crossover Design Study |
| Lead sponsor | Baylor College of Medicine, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | Pramlintide |
| Enrollment | 13 |
| Start date | Jan 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Feb 15, 2006 |
| Last update posted | Jul 14, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: